Peers

ANG Lifesciences India Ltd. is significantly underperforming its peers in the Pharmaceuticals & Drugs sector, characterized by negative revenue growth, earnings, and return on equity. In contrast, companies like Sun Pharmaceutical and Cipla stand out for their strong profitability and growth metrics, making them more attractive investments.

• • ANG Lifesciences has the lowest revenue growth (-33.55%) and EPS (-9.51).
• • Sun Pharmaceutical leads with the highest revenue growth (8.42%) and EPS (45.55).
• • Cipla shows robust profitability metrics with a 16.63% ROE and 13.59% ROA.
• • ANG Lifesciences' high debt-equity ratio (0.91) positions it as financially stressed compared to its peers.

• • Sun Pharmaceutical Industries Ltd.: Highest revenue growth and EPS, indicating strong market performance and profitability.
• • Cipla Ltd.: Robust profitability with solid ROE and ROA metrics, alongside reasonable valuation.
• • Dr. Reddy's Laboratories Ltd.: Strong overall profitability metrics and low debt levels.